Preventive Diagnostics And Automation Will Shape Future Healthcare

Published
21 Aug 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$188.19
4.2% undervalued intrinsic discount
20 Aug
US$180.23
Loading
1Y
17.4%
7D
0.3%

Author's Valuation

US$188.2

4.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 2.78%

Shared on30 Apr 25
Fair value Increased 4.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 3.68%

AnalystConsensusTarget has decreased revenue growth from 5.5% to 4.8%.

Shared on16 Apr 25
Fair value Increased 0.57%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on09 Apr 25
Fair value Increased 0.59%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.29%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.034%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.034%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 4.43%

AnalystConsensusTarget has decreased profit margin from 11.6% to 10.4%.